(Q28301320)

English

Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease

scientific article

Statements

Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease (English)
0 references
0 references
0 references
Antonio M Gotto
0 references
Xiujiang Susie Li
0 references
Sanskruti Vaidya
0 references
Uma Kher
0 references
Michael Davidson
0 references
Jennifer E Moon
0 references
Sukrut Shah
0 references
Hayes M Dansky
0 references
Yale Mitchel
0 references
Philip Barter
0 references
1 January 2014
0 references
113
0 references
1
0 references
76-83
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit